Focused Alpha’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Focused Alpha's BMY Position: Q3 2026 in Review
Focused Alpha reduced its Bristol-Myers Squibb (BMY) stake by 0.73% in Q3 2026, selling an estimated $4.74K and leaving 10,178 shares worth $635K. The position accounts for 0.16% of the portfolio, ranked #120.
Focused Alpha first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Focused Alpha held 10,178 shares of Bristol-Myers Squibb worth $635K as of Q3 2026.
- Focused Alpha sold 75 Bristol-Myers Squibb shares in Q3 2026, an estimated $4.74K.
- Bristol-Myers Squibb made up 0.16% of Focused Alpha's portfolio in Q3 2026, its #120 holding.
- Focused Alpha first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
- 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.